Vaccine Preventable Diseases Flashcards
risk factors for hepb
iv drugs blood products tattoos or acupuncture sex institutional care intimate contact w carriers
clinical manifestations of hepb
- asymptomatic
- fever, anorexia, malaise 6-7 weeks after exposure
- jaundice 8 weeks and lasts 4 weeks
- chronic: hepatitis, cirrhosis, hcc
diagnosis of hepb
acute: hbsag, anti-hbc igm, anti-hbs (recovery)
vaccinated: anti hbsag only
resolved infaction: antihbsag + antihbc
infectivity: hbeag
treatment for hepb
supportive and monitoring
interferon a2b
lamivudine, adefovir, pedinterferon a2
prevention of hepb
vaccine: seropositivity >95% after second dose
birth, 1-2 mos, 6 mos
if >2000g and HBsAg (-) birth, 1-4 mos, 6-18 mos
preterm, <2000g, HBsAg(-) mother: first dose 1 mo age
if hbsag (+) mother: hbig within 12 h
etiology of diptheria
corynebacterium diptheriae and diptheritic toxin
risk factors for diptheria
- large population of underimmunized adults
- decreased childhood immunization
- population migration
- crowding
- failure to respond to epidemic
pathogenesis of diptheria
transmission: airborne respiratory droplets, direct contact with secretions
toxin causes kidney necrosis, thrombocytopenia, cardiomyopathy, demyelination of nerves
clinical manifestations of diptheria
incubation: 2-4 d
most common sites of infection: tonsils or pharynx
key words: serosanguinous, purulent, erosive rhinitis with MEMBRANE FORMATION
respiratory diptheria
unilateral or bilateral tonsillar membrane (gray brown leather)
bull neck appearance
airway compromise
cutaneous diptheria
superficial nonhealing ulcer with gray brown membrane
extremities > trunk or head
complications of diptheria
toxic cardiomyopathy: 50-60% of deaths, dilated and hypertrophic cardiomyopathy
toxic neuropathy: weakness of posterior pharyngeal, laryngeal, and facial nerves (voice and swallowing); cranial neuropathies (eyes)
treatment for diptheria
equine diptheria antitoxin
erythromycin q 6h po/iv
aqueous crystalline penicillin g q 6h iv/im
procaine penicillin
wound care, bed rest
prophylaxis for diptheria
benzathine penicillin g im
erythromycin qid 10 d
prevention of diptheria
dtap/dt: 2, 4, 6 mos, 15-18 mos, 4-6 yo
booster (td/tdap): 11-12 yo
etiology of pertussis
bordatella pertussis and pertussis toxin
clinical manifestations of pertussis
catarrhal phase (1-2 w): congestion
paroxysmal (2-6 w): machine gun dry cough
convalescent (>2 w): less cough
gold standard for pertussis diagnosis
isolation of b pertussis in culture (nasopharyngeal swab)
treatment for pertussis
<3 mos/ preterm/ co-morbids: admit in quiet room
<1 mo-5 mo azithromycin 10 mg/kd/d 5 d
>6 mo azithromycin 10 mg/kg/d day 1, 5 mg/kg/d day 2-5
>1 mo erythromycin (<1 mo = hypertrophic pyloric stenosis)
complications of pertussis
secondary infections
conjunctival and scleral hemorrhage
cns hemorrhage
pulmo hypertension and 2ndary pneumonia (death)
prevention of pertussis
dtap 2, 4, 6, 15-18, 4-6 yo
tdap booster 11-18 yo
etiology of tenanus
clostridium tetani and tetanoplasmin
tennis racket or drumstick
pathogenesis of tetanus
tetanus produce toxin -> binds at nms junction -> enters motor nerve -> cytoplasm of alpha motorneuron -> prevents glycine and gaba release
clinical manifestations of tetanus
incubation: 2-14 d / months
course: 1-4 w
trismus (lockjaw), risus sardonicus (smile), opisthonos, conscious in extreme pain, tetanic seizures
neonatal tetanus
- occurs when mother is not vaccinated
- manifests 3-12 d after birth
diagnosis of tetanus
- hx: unimmunized pt and mother
- injured or born within 2 wks preceding infection
- trismus, rigid muscles, and clear sensorium
treatment for tetanus
- human tetanus ig
- equine or bovine derived tetanus antitoxin
- doc: penicllin g iv
- seizure control
- nm blocking agents
- morphine
t/f children with tetanus can tolerate noise
false, unnecessary sounds/touch can trigger tetanic spasms
prevention of tetanus
dtap: 2, 4, 6 mo
td/tdap: 4-6 yo, intervals of 10 ys
tetanus prophylaxis in uncertain or <3 doses
clean, minor wounds: tdap or td, NO TIG
other wounds: tdap or td with tig
tetanus prophylaxis in >3 doses
clean, minor wounds: NO VACCINE, NO TIG
other wounds: NO VACCINE NO TIG
child is immunized
t/f humans are the only reservoir for poliovirus and spread it by fecal oral route
true
pathogenesis of poliovirus
gi tract -> m cells in small intestine -> peripheral nerves -> anterior horn cells and medulla oblongata
> 50% motor neurons involved = weakness in limbs or paralysis
dorsal horn and dorsal root ganglia = hyperesthesia and myalgia
abortive poliomyelitis
- nonspecific influenza like 1-2 wks
- full recovery
- can spread polio unknowingly
nonparalytic poliomyelitis
- nonspecific
- more intense flu sx
- fleeting paralysis of bladder and constipation
- nuchal and spinal rigidity
spinal paralytic poliomyelitis
1st phase: like abortive myelitis, severe muscle pain, sensory and motor sx, recover in 2-5 d
2nd phase: within 1-2 days asymmetric flaccid paralysis or paresis
PE: nuchal rigidity, muscle tenderness, +++ DTR then — DTR, intact sensation
bulbar poliomyelitis
- dysfunction of cn and medullary centers
- pharyngeal and vocal problems
- deviation of palate, uvula, or tongue
- involves vital centers of medulla (RR, BP, HR, T)
- rope sign
polioencephalitis
- seizures, coma, spastic paralysis
- sensorium changes: irritability, disorientation, drowsiness, coarse tremors
diagnosis of poliovirus
isolation of virus from 2 stool specimens, 24-48 hrs apart
treatment of poliovirus
no specific treatment
if paralytic -> admit (airway compromise)
prevention of poliovirus
ipv (higher igg) opv (mucosal iga)
2, 4, 6-18 mo, 4-6 yo
t/f opv is not recommended by who to eradicate polio
false